Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase.
Ambulatory Care
Betacoronavirus
COVID-19
Coronavirus Infections
/ epidemiology
Cross-Sectional Studies
Health Services Accessibility
/ organization & administration
Hospitalization
Humans
Italy
/ epidemiology
Neuromuscular Diseases
/ therapy
Pandemics
/ prevention & control
Pneumonia, Viral
/ epidemiology
Referral and Consultation
/ organization & administration
SARS-CoV-2
Surveys and Questionnaires
Telemedicine
/ organization & administration
COVID-19
SARS-CoV-2
myastenia gravis
myopathies
neuromuscular diseases
neuromuscular services
neuropathies
Journal
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology
ISSN: 2532-1900
Titre abrégé: Acta Myol
Pays: Italy
ID NLM: 9811169
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
08
06
2020
accepted:
20
06
2020
entrez:
9
9
2020
pubmed:
10
9
2020
medline:
17
9
2020
Statut:
epublish
Résumé
Since February 2020, the outbreak of COVID-19 in Italy has forced the health care system to undergo profound rearrangements in its services and facilities, especially in the worst-hit areas in Northern Italy. In this setting, inpatient and outpatient services had to rethink and reorganize their activities to meet the needs of patients during the "lockdown". The Italian Association of Myology developed a survey to estimate the impact of these changes on patients affected by neuromuscular disorders and on specialized neuromuscular centers during the acute phase of COVID-19 pandemic. We developed an electronic survey that was sent to neuromuscular centers affiliated with the Italian Association of Myology, assessing changes in pharmacological therapies provision, outpatient clinical and instrumental services, support services (physiotherapy, nursing care, psychological support) and clinical trials. 40% of surveyed neuromuscular centers reported a reduction in outpatient visit and examinations (44.5% of centers in Northern regions; 25% of centers in Central regions; 50% of centers in Southern regions). Twenty-two% of centers postponed in-hospital administration of therapies for neuromuscular diseases (23.4% in Northern regions; 13.0% in Central regions; 20% in Southern regions). Diagnostic and support services (physiotherapy, nursing care, psychological support) were suspended in 57% of centers (66/43/44% in Northern, Central and Southern centers respectively) Overall, the most affected services were rehabilitative services and on-site outpatient visits, which were suspended in 93% of centers. Strategies adopted by neuromuscular centers to overcome these changes included maintaining urgent on-site visits, addressing patients to available services and promoting remote contact and telemedicine. Overall, COVID-19 pandemic resulted in a significant disruption of clinical and support services for patients with neuromuscular diseases. Despite the efforts to provide telemedicine consults to patients, this option could be promoted and improved further. A close collaboration between the different neuromuscular centers and service providers as well as further implementation of telehealth platforms are necessary to ensure quality care to NMD patients in the near future and in case of recurrent pandemic waves.
Identifiants
pubmed: 32904925
doi: 10.36185/2532-1900-008
pmc: PMC7460733
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
57-66Informations de copyright
©2020 Gaetano Conte Academy - Mediterranean Society of Myology, Naples, Italy.
Références
Muscle Nerve. 2020 Jul;62(1):46-49
pubmed: 32329921
Neurology. 2020 Jun 2;94(22):959-969
pubmed: 32284362
Int J Environ Res Public Health. 2020 Apr 16;17(8):
pubmed: 32316337
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Lancet Child Adolesc Health. 2020 May;4(5):e10-e11
pubmed: 32278365
BMJ. 2020 Mar 26;368:m1254
pubmed: 32217525
Muscle Nerve. 2019 Dec;60(6):693-699
pubmed: 31469909
JAMA Psychiatry. 2020 Sep 1;77(9):974-976
pubmed: 32352480
Continuum (Minneap Minn). 2020 Jun;26(3):785-798
pubmed: 32487907
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Lancet. 2020 Mar 14;395(10227):e49-e50
pubmed: 32119824
Infez Med. 2020 Ahead of print Jun 1;28(2):133-134
pubmed: 32275253
N Engl J Med. 2020 May 21;382(21):e71
pubmed: 32369276
Diagnosis (Berl). 2020 May 26;7(2):85-90
pubmed: 32267243
Muscle Nerve. 2020 Jul;62(1):41-45
pubmed: 32329920
Eur J Phys Rehabil Med. 2020 Jun;56(3):316-318
pubmed: 32175719
Clin Microbiol Infect. 2020 Jul;26(7):880-894
pubmed: 32360444
J Neurol Sci. 2020 May 15;412:116803
pubmed: 32247193
Int J Environ Res Public Health. 2020 Apr 27;17(9):
pubmed: 32349253